The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Reports of Anaphylaxis After Receipt of mRNA COVID-19 Vaccines in the US—December 14, 2020-January 18, 2021
Open accessAbstract
This JAMA Insights review provides clinical details of anaphylactic reactions reported to and verified by the CDC in the first month of use of the Pfizer-BioNTech and Moderna COVID-19 vaccines in the US, December 14, 2020-January 18, 2021.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Anaphylactic reactions have been observed in approximately 4.7 per million anti-COVID-19 vaccinations with the Pfizer–BioNTech vaccine and 2.5 per million vaccinations with the Moderna vaccine213”
From mRNA vaccines for infectious diseases: principles, delivery and clinical translation (2021) · cites this paper as [213]
In the citing paper
“Anaphylactic reactions have been observed in approximately 4.7 per million anti-COVID-19 vaccinations with the Pfizer–BioNTech vaccine and 2.5 per million vaccinations with the Moderna vaccine213”
From mRNA vaccines for infectious diseases: principles, delivery and clinical translation (2021) · cites this paper as [213]
In the citing paper
“Rare events of anaphylaxis have been reported after vaccination with mRNA-1273 and BNT162b2, with an incidence currently estimated at approximately 1 in 100,000 [86].”
From The dawn of mRNA vaccines: the COVID-19 case (2021) · cites this paper as [86]
In the citing paper
“Of the confirmed cases, most of the individuals had a documented history of allergic reactions and/or anaphylaxis.”
From The dawn of mRNA vaccines: the COVID-19 case (2021) · cites this paper as [86]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS)
Shimabukuro, T. T., Nguyen, M., Martin, D., & Destefano, F. R. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.07.035 · Cited by 627
Self-citationOliver, S. E., Gargano, J. W., Marin, M., Wallace, M. M., Curran, K. G., Chamberland, M. E., McClung, N. M., Campos-Outcalt, D. E., Morgan, R. L., Mbaeyi, S. A., et al. (2020) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6950e2 · Cited by 536
Rüggeberg, J. U., Gold, M., Bayas, J. M., Blum, M. D., Bonhoeffer, J., Friedlander, S. F., Brito, G. D. S., Heininger, U., Imoukhuede, E. B., Khamesipour, A., et al. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.02.064 · Cited by 383
Rossen, L. M., Branum, A. M., Ahmad, F. B., Sutton, P., & Anderson, R. N. (2020) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6942e2 · Cited by 373
Shimabukuro, T. T., & Nair, N. (2021) · JAMA · doi:10.1001/jama.2021.0600 · Cited by 327
Self-citationOliver, S. E., Gargano, J. W., Marin, M., Wallace, M. M., Curran, K. G., Chamberland, M. E., McClung, N. M., Campos-Outcalt, D. E., Morgan, R. L., Mbaeyi, S. A., et al. (2020) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm695152e1 · Cited by 317
Vaccine-associated hypersensitivity
McNeil, M. M., & Destefano, F. R. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.12.971 · Cited by 274
CDC COVID-19 Response Team, & Administration, F. A. D. (2021) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm7004e1 · Cited by 270
Cited by
Sorted by citations
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
Chaudhary, N., Weissman, D., & Whitehead, K. A. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00283-5 · Cited by 1,555
Tregoning, J. S., Flight, K. E., Higham, S. L., Wang, Z., & Pierce, B. F. (2021) · Nature reviews. Immunology · doi:10.1038/s41577-021-00592-1 · Cited by 1,146
McMahon, D. E., Amerson, E. H., Rosenbach, M. A., Lipoff, J. B., Moustafa, D., Tyagi, A., Desai, S. R., French, L. E., Lim, H. W., THIERS, B. H., et al. (2021) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2021.03.092 · Cited by 808
Surveillance for Adverse Events After COVID-19 mRNA Vaccination
Klein, N. P., Lewis, N., Goddard, K., FIREMAN, B. H., Zerbo, O., Hanson, K. E., Donahue, J. G., Kharbanda, E. O., Naleway, A. L., Nelson, J. C., et al. (2021) · JAMA · doi:10.1001/jama.2021.15072 · Cited by 633
Self-citationUnlocking the promise of mRNA therapeutics
Rohner, E., Yang, R., Foo, K. S., Goedel, A., & Chien, K. R. (2022) · Nature Biotechnology · doi:10.1038/s41587-022-01491-z · Cited by 612
Metadata
- Authors
- Shimabukuro, T. T., Cole, M., & Su, J. R.
- Affiliations
- Centers for Disease Control and Prevention (US)
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2021-03-16
- Volume
- 325
- Issue
- 11
- Pages
- 1101
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- PMC
- PMC8890485
- OpenAlex
- W3128551684
- Cited by
- 475
- References
- 8
- Citations by year
- 2026: 22 · 2025: 27 · 2024: 30 · 2023: 104 · 2022: 136 · 2021: 156
- FWCI
- 33.73
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- JAMA (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (CC999999)
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
- Health Sciences › Medicine › Immunology and Allergy › Food Allergy and Anaphylaxis Research
- Keywords
- anaphylaxis, COVID-19 mRNA vaccine, BNT162b2, Moderna vaccine, vaccine adverse events, vaccine safety
- MeSH terms
- COVID-19 Vaccines, Adult, Anaphylaxis, Female, Hospitalization, Humans, Male, Middle Aged, United States, Adverse Drug Reaction Reporting Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
